loadpatents
name:-0.080316066741943
name:-0.034234046936035
name:-0.0026910305023193
Tang; Datong Patent Filings

Tang; Datong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tang; Datong.The latest application filed is for "processes for the preparation of novel benzimidazole derivatives".

Company Profile
1.37.35
  • Tang; Datong - Newton MA
  • - Newton MA US
  • Tang; Datong - Watertown MA
  • Tang; Datong - Malden MA
  • Tang; Datong - Brighton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
Grant 9,242,974 - Xu , et al. January 26, 2
2016-01-26
Quinoxalinyl derivatives
Grant 8,962,551 - Niu , et al. February 24, 2
2015-02-24
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
Grant 8,927,739 - Qiu , et al. January 6, 2
2015-01-06
Processes for the preparation of novel benzimidazole derivatives
Grant 08921573 -
2014-12-30
Processes for the preparation of novel benzimidazole derivatives
Grant 8,921,573 - Tang , et al. December 30, 2
2014-12-30
Processes For The Preparation Of Novel Benzimidazole Derivatives
App 20140316143 - Tang; Datong ;   et al.
2014-10-23
Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
Grant 8,809,264 - Niu , et al. August 19, 2
2014-08-19
Hepatitis C virus inhibitors
Grant 8,778,938 - Qiu , et al. July 15, 2
2014-07-15
Processes For The Preparation Of 5-azaspiro[2.4]heptane-6-carboxylic Acid And Its Derivatives
App 20140187793 - Qiu; Yao-Ling ;   et al.
2014-07-03
Processes For The Preparation Of 2-fluoro 6-11 Bicyclic Erythromycin Derivatives
App 20140073797 - Xu; Guoyou ;   et al.
2014-03-13
Hepatitis C virus inhibitors
Grant 8,609,648 - Or , et al. December 17, 2
2013-12-17
Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
Grant 8,552,162 - Xu , et al. October 8, 2
2013-10-08
Macrocyclic hepatitis C virus serine protease inhibitors
Grant 8,501,681 - Niu , et al. August 6, 2
2013-08-06
Hepatitis C Virus inhibitors
Grant 8,426,458 - Or , et al. April 23, 2
2013-04-23
Linked diimidazole antivirals
Grant 8,420,686 - Or , et al. April 16, 2
2013-04-16
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Grant 8,236,807 - Nakajima , et al. August 7, 2
2012-08-07
Macrocyclic hepatitis C serine protease inhibitors
Grant 8,124,584 - Miao , et al. February 28, 2
2012-02-28
Hepatitis C Virus Inhibitors
App 20110300104 - Qiu; Yao-Ling ;   et al.
2011-12-08
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Grant RE42,375 - Nakajima , et al. May 17, 2
2011-05-17
Processes for the preparation of hydroxylamines
Grant 7,919,627 - Tang , et al. April 5, 2
2011-04-05
Hepatitis C Virus Inhibitors
App 20110008288 - Or; Yat Sun ;   et al.
2011-01-13
Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
Grant 7,842,813 - Tang , et al. November 30, 2
2010-11-30
Linked Diimidazole Antivirals
App 20100226882 - Or; Yat Sun ;   et al.
2010-09-09
Hepatitis C Virus Inhibitors
App 20100221216 - Or; Yat Sun ;   et al.
2010-09-02
Tri-peptide hepatitis C serine protease inhibitors
Grant 7,718,769 - Miao , et al. May 18, 2
2010-05-18
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
Grant 7,718,612 - Moore , et al. May 18, 2
2010-05-18
Quinoxalinyl Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20100015092 - Nakajima; Suanne ;   et al.
2010-01-21
Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20090304629 - Miao; Zhenwei ;   et al.
2009-12-10
Processes For The Preparation Of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
App 20090281324 - Tang; Datong ;   et al.
2009-11-12
Processes For The Preparation Of 2 Fluoro 6-11 Bicyclic Erythromycin Derivatives
App 20090281293 - Xu; Guoyou ;   et al.
2009-11-12
Macrocyclic hepatitis C serine protease inhibitors
Grant 7,601,709 - Miao , et al. October 13, 2
2009-10-13
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Grant 7,566,719 - Nakajima , et al. July 28, 2
2009-07-28
Quinoxalinyl Derivatives
App 20090180981 - Niu; Deqiang ;   et al.
2009-07-16
Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
Grant 7,538,225 - Tang , et al. May 26, 2
2009-05-26
Spirocyclic bicyclolides
Grant 7,517,859 - Gai , et al. April 14, 2
2009-04-14
Acyclic, Pyridazinone-derived Hepatitis C Serine Protease Inhibitors
App 20090035267 - Moore; Joel D. ;   et al.
2009-02-05
Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20090035272 - Moore; Joel D. ;   et al.
2009-02-05
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20090005387 - Niu; Deqiang ;   et al.
2009-01-01
Polymorphic Forms Of 6-11 Bicyclic Ketolide Derivatives
App 20080248105 - Tang; Datong ;   et al.
2008-10-09
Processes For The Preparation Of Hydroxylamines
App 20080242865 - Tang; Datong ;   et al.
2008-10-02
Quinoxalinyl Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20080152622 - Nakajima; Suanne ;   et al.
2008-06-26
Polymorphic forms of 6-11 bicyclic ketolide derivatives
Grant 7,384,921 - Tang , et al. June 10, 2
2008-06-10
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Grant 7,368,452 - Nakajima , et al. May 6, 2
2008-05-06
Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20080008681 - Niu; Deqiang ;   et al.
2008-01-10
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20070299078 - Niu; Deqiang ;   et al.
2007-12-27
Tetracyclic bicyclolides
Grant 7,312,201 - Tang , et al. December 25, 2
2007-12-25
11,12-lactone bicyclolides
Grant 7,291,602 - Tang , et al. November 6, 2
2007-11-06
Tri-peptide hepatitis C serine protease inhibitors
Grant 7,273,851 - Miao , et al. September 25, 2
2007-09-25
Tri-peptide hepatitis C serine protease inhibitors
App 20070161575 - Miao; Zhenwei ;   et al.
2007-07-12
3,6-Bicyclolides
Grant 7,229,972 - Or , et al. June 12, 2
2007-06-12
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
App 20070060510 - Nakajima; Suanne ;   et al.
2007-03-15
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Grant 7,176,208 - Nakajima , et al. February 13, 2
2007-02-13
Spirocyclic bicyclolides
App 20060252713 - Gai; Yonghua ;   et al.
2006-11-09
Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
App 20060247440 - Tang; Datong ;   et al.
2006-11-02
11,12-Lactone bicyclolides
App 20060148731 - Tang; Datong ;   et al.
2006-07-06
Tetracyclic bicyclolides
App 20060142215 - Tang; Datong ;   et al.
2006-06-29
3,6-bicyclolides
App 20060142214 - Or; Yat Sun ;   et al.
2006-06-29
3,6-Bicyclolides
App 20060122128 - Or; Yat Sun ;   et al.
2006-06-08
Processes for the preparation of 6-11 bicyclic erythromycin derivatives
App 20060058248 - Xu; Guoyou ;   et al.
2006-03-16
Tri-peptide hepatitis C serine protease inhibitors
App 20050261200 - Miao, Zhenwei ;   et al.
2005-11-24
Polymorphic forms of 6-11 bicyclic ketolide derivatives
App 20050203035 - Tang, Datong ;   et al.
2005-09-15
Macrocyclic hepatitis C serine protease inhibitors
App 20050153877 - Miao, Zhenwei ;   et al.
2005-07-14
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
App 20040266668 - Nakajima, Suanne ;   et al.
2004-12-30
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
App 20040180815 - Nakajima, Suanne ;   et al.
2004-09-16
Processes for the preparation of 6-11 bicyclic erythromycin derivatives
App 20040171818 - Xu, Guoyou ;   et al.
2004-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed